Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy

Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review

(2015) Katrin Jekel et al.   Alzheimers Research & Therapy

Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

(2014) David Wilkinson et al.   LANCET NEUROLOGY

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

(2014) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cerebral inflammation is an underlying mechanism of early death in Alzheimer’s disease: a 13-year cause-specific multivariate mortality study

(2014) Katarina Nägga et al.   Alzheimers Research & Therapy

Solitary living in Alzheimer’s disease over 3 years: association between cognitive and functional impairment and community-based services

(2014) Carina Wattmo et al.   Clinical Interventions in Aging

Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force

(2013) Bruno Vellas et al.   Alzheimers & Dementia

Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

(2013) Carina Wattmo et al.   Alzheimers Research & Therapy

Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies

(2013) Carina Wattmo et al.   Alzheimers Research & Therapy

Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-AD

(2011) Cheryl L.P. Vigen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative

(2011) Lon S. Schneider   ARCHIVES OF NEUROLOGY

Predictors of long-term cognitive outcome in Alzheimer's disease

(2011) Carina Wattmo et al.   Alzheimers Research & Therapy

Long-term Outcome and Prediction Models of Activities of Daily Living in Alzheimer Disease With Cholinesterase Inhibitor Treatment

(2010) Carina Wattmo et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease

(2010) Gary Small et al.   Alzheimers & Dementia

Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial

(2009) Robert C. Green   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predicting Long-Term Cognitive Outcome with New Regression Models in Donepezil-Treated Alzheimer Patients in a Naturalistic Setting

(2008) Carina Wattmo et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS